2016 New Hampshire Revised Statutes
Title X - PUBLIC HEALTH
Chapter 126-A - DEPARTMENT OF HEALTH AND HUMAN SERVICES
Section 126-A:69 - Commission Established; Membership; Duties.

[RSA 126-A:69 repealed by 2016, 1:1, effective November 1, 2017.]     126-A:69 Commission Established; Membership; Duties. –
    I. There is established a commission to study Narcan.
       (a) The members of the commission shall be as follows:
          (1) Two members of the senate, one of whom shall be appointed by the president of the senate, and one of whom shall be appointed by the senate minority leader.
          (2) Two members of the house of representatives, one of whom shall be appointed by the speaker of the house of representatives, and one of whom shall be appointed by the house minority leader.
          (3) The commissioner of the department of health and human services, or designee.
          (4) A pharmacist, appointed by the board.
          (5) A licensed alcohol and drug counselor, appointed by the chairperson of the board of licensing for alcohol and other drug use professionals.
          (6) A licensed physician, appointed by the board of medicine.
          (7) An emergency medical technician, appointed by the director of the division of fire standards and training and emergency medical services, department of safety.
          (8) A police officer, appointed by the senate president.
          (9) An APRN, appointed by the New Hampshire Nurse Practitioner Association.
          (10) A public member, appointed by the governor.
          (11) A public member, appointed by the senate president.
          (12) A public member, appointed by the speaker of the house of representatives.
       (b) Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
    II. (a)(1) The commission shall study all aspects of Narcan, including, but not limited to:
             (A) Whether there should be a registry established for those in possession of Narcan.
             (B) The training required regarding dosage, conditions for administering Narcan, and other appropriate training.
             (C) Whether there should be mandatory reporting of use of Narcan.
             (D) Whether those persons who are administered Narcan should be required to go to outpatient treatment for a certain period of time.
          (2) The commission shall produce a long-term plan on the use and distribution of Narcan.
       (b) The commission shall solicit information from any person or entity the commission deems relevant to its study.
    III. The members of the commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the first-named senate member. The first meeting of the commission shall be held within 45 days of the effective date of this section. Six members of the commission shall constitute a quorum.
    IV. The commission shall make an interim report within 6 months of the effective date of this section, and a final report on November 1, 2017 indicating its findings and any recommendations for proposed legislation to the president of the senate, the speaker of the house of representatives, the senate clerk, the house clerk, the governor, and the state library.

Source. 2016, 1:1, eff. Jan. 21, 2016.